Financials

  • Market Capitalization 271.99 M
  • Employee 35
  • Founded 2008
  • CEO N/A
  • Website www.inhibikase.com
  • Headquarter Delaware, United States
  • FIGI BBG005TP2339
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-3.82
市销率
43.33

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
3410
MGNX
MacroGenics, Inc. - Common Stock
4.32 USD+0.70%-6.70%+4.10%+188.00%274.59 M USD
3414
ALXO
ALX Oncology Holdings Inc. - Common Stock
2.03 USD+1.50%-12.88%+27.67%+331.91%273.16 M USD
3461
RNAC
Cartesian Therapeutics, Inc. - Common Stock
8.68 USD+0.70%-14.65%+0.70%-5.24%255.03 M USD
3469
SRZN
Surrozen, Inc. - Common Stock
21.79 USD-0.41%-5.92%-6.04%+161.90%252.99 M USD

新闻